Formulation, Development and Manufacturing of Vaccines - 1st Edition - ISBN: 9780128143575

Formulation, Development and Manufacturing of Vaccines

1st Edition

The Practical Aspects

Editors: Satoshi Ohtake Parag Kolhe
Paperback ISBN: 9780128143575
Imprint: Academic Press
Published Date: 1st May 2019
Page Count: 410
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Formulation, Development and Manufacturing of Vaccines: The Practical Aspects provides an industry perspective on vaccine product development and manufacture. With the increasing complexity of vaccine products in development, there is a need for a comprehensive review of the current state of the industry and challenges being encountered. While formulation scientists working in biotherapeutic development may be familiar with proteins, vaccines present unique challenges, which include the wide range of vaccine components that may comprise of proteins, polysaccharides, protein-polysaccharide conjugates, adjuvants, etc,. and also the varying stability and behavior of solution- and suspension-based systems. The container closure system may also be unique and the product may require freezing storage or lyophilization based on the stability of the vaccine components. Based on the route of delivery, novel technologies and devices may be required. Covering formulation development, manufacture, and delivery/in-use considerations of vaccine production, this book is essential to formulation scientists, researchers in vaccine development throughout medical and life sciences, and advanced students.

Key Features

  • Includes formulation considerations for various vaccine types, including proteins, polysaccharides, conjugates, and live vaccines
  • Considerations of process development for solution, suspension, and lyophilized products
  • Exploration of future potential inlcuding multi-component vaccines and novel delivery mechanisms/devices

Readership

Formulation scientists, pharmacists, bioengineers, chemists or physicists in the pharmaceutical industry. Researchers and advanced students in pharmaceutical sciences

Table of Contents

Section 1 Formulation Development
1. Introduction to vaccine formulation development
2. Overview of vaccine antigens
3. Overview of vaccine adjuvants
4. Formulation considerations for Live attenuated vaccines
5. Subunit based vaccines: Challenges in developing protein based vaccines
6. Subunit based vaccines: Challenges in developing polysaccharide based and conjugate vaccines
7. DNA vaccines
8. New frontiers in cancer vaccines
9. Adjuvant formulation development
10. Antigen-adjuvant formulation- Key considerations
11. Colloidal stability of suspension systems

Section 2 Process Development
12. Introduction to drug product process development for vaccines
13. Process development and scale up aspects for suspension vaccines
14. Effect of shipping stress on suspension vaccines
15. Developing control strategy for final dose concentration- Case study
16. Lyophilized vaccine development
17. Approaches for stabilizing vaccine antigens through spray drying
18. Regulatory requirements for drug product process: Lot consistency, process performance qualification and post approval changes

Section 3 Delivery
19. Combination product rule requirements for vaccines – Challenges and strategies
20. Potential of micro-needle based vaccine delivery
21. Challenges in assessing in-use stability of admixture (antigen-adjuvant mixture) prior to administration

Details

No. of pages:
410
Language:
English
Copyright:
© Academic Press 2019
Published:
Imprint:
Academic Press
Paperback ISBN:
9780128143575

About the Editor

Satoshi Ohtake

Dr. Ohtake is an R&D professional with over 10 years of experience in the biotechnology industry, focusing on formulation and process development of various modalities ranging from small molecules to live attenuated vaccines. He has held positions of increasing responsibility at Nektar Therapeutics, Aridis Pharmaceuticals, and Pfizer, demonstrating capability to lead cross-functional teams to success. Adept at working in various environments with experience in small start-up as well as large global pharma. Dr. Ohtake is the inventor of over 10 patents and patent applications, author of over 30 articles in peer-reviewed journals and more than 15 invited presentations. He received his B.S. from Caltech and Ph.D. from the University of Wisconsin in Chemical Engineering. Currently serving on the Journal of Pharmaceutical Sciences Editorial Advisory Board and the Caltech Alumni Association Board of Directors.

Affiliations and Expertise

Senior Director in Pharmaceutical R&D, Biotherapeutics Pharmaceutical Sciences, Pfizer, St. Louis, MO, USA

Parag Kolhe

Dr. Kolhe is an active leader and participant in the biotherapeutic community through the American Association of Pharmaceutical Sciences (AAPS) and The Pharmacists' Defence Association (PDA) as conference organizer, chair, moderator, invited speaker. He has expertise in the field of biotherapeutics and has developed, influenced and transformed control strategy approach into workable solution within Pfizer for biotherapeutics products. Dr. Kolhe has authored more than 18 peer reviewed journal articles, patents and been a book editor. He received his BE in Polymer Engineering from the University of Pune, India and his Ph.D. in Material Science and Engineering from Wayne State University, Detroit, USA.

Affiliations and Expertise

Group Leader, Associate Research Fellow, Biotherapeutics Pharmaceutical Sciences, Pfizer, St. Louis, MO, USA

Ratings and Reviews